Repurposing SGLT2 inhibitors for autoimmune diseases? YES, WE MAY! (2023)

First Author: Certo M

Attributed to: Centre for Musculoskeletal Ageing Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2023.07.020

PubMed Identifier: 37738952

Publication URI: http://europepmc.org/abstract/MED/37738952

Type: Journal Article/Review

Volume: 30

Parent Publication: Cell chemical biology

Issue: 9

ISSN: 2451-9448